Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Buy
5,348
+10
+0.2% +$1.21K 0.02% 460
2026
Q1
$873K Buy
5,338
+13
+0.2% +$2K 0.03% 336
2025
Q4
$927K Buy
5,325
+146
+3% +$26.6K 0.03% 312
2025
Q3
$746K Sell
5,179
-237
-4% -$29K 0.03% 349
2025
Q2
$545K Buy
5,416
+940
+21% +$71.9K 0.02% 413
2025
Q1
$341K Buy
+4,476
New +$342K 0.01% 495

Other funds holding INSM

Fulton Bank's INSM Position: Q2 2026 in Review

Fulton Bank increased its Insmed (INSM) stake by 0.19% in Q2 2026, buying an estimated $1.21K and bringing the position to 5,348 shares worth $570K. The position accounts for 0.02% of the portfolio, ranked #460.

Fulton Bank first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $927K in Q4 2025. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Fulton Bank held 5,348 shares of Insmed worth $570K as of Q2 2026.
  • Fulton Bank bought 10 Insmed shares in Q2 2026, an estimated $1.21K.
  • Insmed made up 0.02% of Fulton Bank's portfolio in Q2 2026, its #460 holding.
  • Fulton Bank first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
  • Fulton Bank's Insmed position peaked at $927K in Q4 2025.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.